“Stroke Drug Development:  Bridging the Gap from Animal Research to Human Trials”

 

STAIR I Sponsors

Abbott Laboratories

Astra Arcus USA

Astra Pharmaceuticals

Boehringer Ingelheim

Bristol-Myers Squibb

Dupont Pharmaceuticals, Inc.

Eli Lilly & Co.

Glaxo Wellcome

Genentech Inc.

Hoffman-La Roche

Janssen Pharmaceutica

Knoll

Parke-Davis

Pfizer LTD

Pharmacia & Upjohn, Inc.

Schering

SmithKline Beecham Pharmaceuticals

Elan Pharmaceuticals

Daiichi

Fujisawa Inst. of Neurosciences

NPS Pharmaceuticals

Interneuron Pharmaceuticals, Inc.

Guilford Pharmaceuticals

Creative BioMolecules

Biogen Inc.

Proscript Inc.

Synzyme Technologies

RePharma, Inc.

Toray

Quintiles

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group